Enteral and parenteral nutrition nursing: a guide for nursing students

LS
By Lindsay Smith, AGPCNP
Updated May 5, 2026

Reviewed for clinical accuracy · Methodology: NIH, NCBI, AANP guidelines

When a patient cannot meet nutritional needs through oral intake, two pathways exist: deliver nutrients through the gastrointestinal tract (enteral nutrition), or bypass the gut entirely and infuse nutrients directly into the bloodstream (parenteral nutrition). The clinical decision between them hinges on one question: is the gastrointestinal tract functional? If it is, enteral nutrition is always the preferred route. Parenteral nutrition is reserved for patients whose gut cannot be used safely.

Both modalities require careful nursing management. Enteral feeding carries risks of aspiration, tube displacement, and diarrhea. Parenteral nutrition carries risks of central line-associated bloodstream infection (CLABSI), hyperglycemia, and metabolic complications including refeeding syndrome. This guide covers both in full — from route selection and administration protocols to monitoring parameters and NCLEX-high-yield facts.


Quick reference: enteral vs parenteral nutrition

Feature Enteral nutrition (EN) Parenteral nutrition (PN)
Primary indication Functional GI tract, unable to eat orally Non-functional GI tract, bowel obstruction, severe malabsorption
Access route NG tube, NJ tube, PEG, PEJ, jejunostomy Central venous catheter (TPN) or peripheral IV (PPN)
Osmolarity limit No limit (stomach tolerates high osmolarity) TPN >900 mOsm/L requires central line; PPN ≤900 mOsm/L
Dedicated line required No (tube used for feeds, meds, and flushing) Yes — TPN must run in a dedicated IV lumen. No piggybacking medications
Glucose monitoring q4–6h if on continuous feeds or patient is diabetic q4–6h (mandatory); target 140–180 mg/dL in critical care
Major complications Aspiration, tube displacement, diarrhea, refeeding syndrome CLABSI, hyperglycemia, hypertriglyceridemia, refeeding syndrome

Enteral nutrition: indications and route selection

Enteral nutrition first. The gut is not just a conduit for nutrients — it plays an active role in immune function, gut barrier integrity, and microbiome maintenance. Enteral feeding preserves the gut mucosal barrier, reducing bacterial translocation and systemic inflammation. Any time a functional GI tract is present, enteral nutrition is preferred over parenteral.

Indications for enteral nutrition:

  • Dysphagia (stroke, head and neck cancer, neurological disease)
  • Impaired consciousness or altered mental status
  • Anorexia or inadequate oral intake despite functional gut
  • Increased metabolic demands the patient cannot meet orally (burns, trauma, critical illness)
  • Pancreatitis — enteral feeds into the jejunum can often be maintained even in acute pancreatitis (see pancreatitis nursing care for details)

Contraindications to enteral nutrition:

  • Bowel obstruction (mechanical or paralytic)
  • Severe malabsorption
  • High-output fistula distal to the feeding point
  • Hemodynamic instability severe enough that gut perfusion is compromised
  • Bowel ischemia

Route selection

Route Access type Duration Indication Key consideration
Nasogastric (NG) Tube through nose to stomach Short-term (<4–6 weeks) Most common; functional stomach, no aspiration risk factors Verify placement before each feed; pH ≤5.5 for gastric; X-ray is gold standard. See NG tube insertion guide
Nasojejunal (NJ) Tube through nose to jejunum (post-pyloric) Short-term High aspiration risk, gastroparesis, pancreatitis X-ray mandatory to confirm post-pyloric position before starting feeds; continuous feeds only (no bolus)
PEG (percutaneous endoscopic gastrostomy) Tube placed endoscopically into stomach through abdominal wall Long-term (>4–6 weeks) Neurological dysphagia, head and neck cancer, prolonged tube feeding need Wait 24 hours after placement before initiating feeds; monitor stoma site for leakage and infection
PEJ (percutaneous endoscopic jejunostomy) Tube placed endoscopically into jejunum through abdominal wall Long-term Gastroparesis, gastric outlet obstruction, high aspiration risk needing long-term feeding Continuous feeds only; flush carefully (small bore clogs easily)
Surgical jejunostomy Tube placed surgically into jejunum Long-term, often post-surgery Upper GI surgery, esophageal resection, pancreatectomy Often placed intraoperatively; continuous feeds only; small bore requires frequent flushing

Tube feeding methods and administration

Feeding methods

Continuous feeds: Formula infuses at a constant rate over 16–24 hours via pump. Used for critically ill patients, ICU patients, jejunal feeding routes (NJ, PEJ, jejunostomy), and anyone at high aspiration risk. Offers the most controlled delivery and lowest gastric residual volumes.

Intermittent feeds: Formula infuses over 30–60 minutes, several times per day (typically 4–6 times), mimicking meal intervals. Suitable for stable patients tolerating gastric feeding. Allows more patient mobility between infusions.

Bolus feeds: 200–500 mL delivered by gravity or syringe over 15–30 minutes, 3–6 times daily. Most closely mimics normal eating. Appropriate only for patients with functioning stomachs and no aspiration risk. Never used with post-pyloric routes.

Aspiration prevention — mandatory nursing practice

Aspiration pneumonia is the most dangerous complication of enteral nutrition. These precautions are non-negotiable:

  • Head of bed (HOB) 30–45° at all times during feeding and for 30–60 minutes after bolus feeds. This single intervention has the strongest evidence for aspiration prevention.
  • Gastric residual volume (GRV) checks q4h for continuous gastric feeds. If GRV exceeds the institution threshold (commonly 200–500 mL), hold the feed, reassess in 1 hour, and notify the provider if elevated GRV persists.
  • Reassess GRV policy: Evidence has shifted — many institutions have moved away from routine GRV checks for stable patients, citing poor correlation with aspiration risk. Know your facility’s protocol.
  • Use post-pyloric routes (NJ, PEJ) for patients with documented gastroparesis or recurrent aspiration events.

Tube placement verification

Verifying correct tube position before every feed is a patient safety imperative. Misplaced tubes have caused deaths from pulmonary aspiration of formula.

  • X-ray (gold standard): Required for all initial placements and any time tube position is uncertain. X-ray is the only method that definitively confirms tube tip location.
  • pH testing of aspirate: Gastric aspirate pH ≤5.5 strongly suggests gastric placement. pH >5.5 may indicate respiratory or intestinal placement.
  • Auscultation is unreliable and must NOT be used as the sole verification method. The traditional “whoosh” test cannot distinguish gastric from pulmonary placement. NCLEX will test this.
  • If a patient coughs, gags, or becomes cyanotic during or after tube insertion, stop immediately and check placement.

Flushing protocol

  • Flush with 30 mL of water before and after every medication administration and every 4–6 hours during continuous feeds.
  • After bolus or intermittent feeds, flush at the end of each feeding.
  • Use water for flushing (not formula). Cranberry juice and cola are not effective at clearing clots and can worsen occlusion.
  • If the tube clogs, attempt to clear with warm water and a 10 mL syringe using gentle push-pull pressure. Do not use a wire stylet to unclog — this risks GI perforation.

Formula selection

Formula typeIndicationKey feature
Standard polymericMost patients with intact GI functionIntact proteins and complex carbohydrates; requires normal digestion
Semi-elementalMalabsorption, pancreatitis, short bowel syndromePartially hydrolyzed proteins; easier absorption
ElementalSevere malabsorption, inflammatory bowel disease, critical illnessFree amino acids, simple sugars; minimal digestion required
Renal-specificCKD, ESRD — see CKD/ESRD nursingLow phosphorus, potassium, and sodium; often concentrated
Diabetic-specificHyperglycemia-prone patientsLower carbohydrate, higher fat and fiber; blunts glucose spike
Pulmonary-specificARDS, chronic respiratory failureHigher fat, lower carbohydrate — reduces CO₂ production
Hepatic-specificHepatic encephalopathyHigher branched-chain amino acids, lower aromatic amino acids

Enteral nutrition complications

Aspiration: Highest-risk complication. Prevention: HOB 30–45°, GRV checks, post-pyloric placement for high-risk patients. Signs: sudden respiratory distress, new infiltrates on chest X-ray, fever after feeding.

Diarrhea: Common with enteral feeds. Causes include high osmolarity formula, fast infusion rate, formula contamination, antibiotic-associated diarrhea (Clostridioides difficile), or sorbitol-containing medications given through the tube. Interventions: reduce rate, change to fiber-containing formula, rule out C. diff, review medications.

Tube clogging: More common with small-bore tubes and thickened medications. Prevention: flush q4–6h with 30 mL water and after every medication. If clogged, attempt warm water flush with gentle pressure. Consider using a medication declogging kit per institution protocol.

Nausea and vomiting: Often related to rate, formula osmolarity, or delayed gastric emptying. Reduce infusion rate, try a lower-osmolarity formula, or switch to post-pyloric delivery. Notify the provider — may need a promotility agent (e.g., metoclopramide).

Tube displacement: NG tubes can migrate out of the stomach or — rarely — into the esophagus or airway. Always verify placement before initiating or resuming feeds after any interruption. Mark the tube at the nares and document the external length; check that mark at every assessment. Never re-advance a tube that has migrated without a new X-ray.


Parenteral nutrition: indications and access

When parenteral nutrition is indicated

Parenteral nutrition (PN) is for patients whose GI tract cannot be used:

  • Bowel obstruction (mechanical or paralytic ileus lasting more than 5–7 days)
  • Short bowel syndrome with severe malabsorption
  • High-output enterocutaneous fistula
  • Severe inflammatory bowel disease (active flare with non-functional gut)
  • Prolonged NPO status (typically >7 days) where enteral access cannot be established
  • Severe pancreatitis when enteral access is not achievable (though enteral is strongly preferred — see pancreatitis nursing care)

TPN vs PPN

Total parenteral nutrition (TPN) provides complete nutrition through a central venous catheter (subclavian, internal jugular, or PICC). TPN solutions are hyperosmolar (typically 1,500–2,500 mOsm/L or higher) and will sclerose peripheral veins. Central access is mandatory. See central line nursing care for central venous catheter management.

Peripheral parenteral nutrition (PPN) can be administered through a large peripheral IV, but is limited to solutions ≤900 mOsm/L. PPN provides incomplete nutrition (insufficient caloric density through a peripheral vein) and is only appropriate for short-term bridging (≤2 weeks) while central access is established.

Dedicated line rule

TPN must run in a dedicated IV lumen — no medications piggybacked, no blood draws through the same lumen. This is both an infection control measure and a compatibility issue: TPN is a complex mixture that can interact chemically with medications. Only lipid emulsion (if given separately as 3-in-1 is not available) may run as directed by pharmacy protocol. Verify with pharmacy before co-administering anything through the TPN lumen.

Inline filters

  • 0.22 μm filter: Used for dextrose and amino acid solutions (2-in-1 PN without lipids)
  • 1.2 μm filter: Required for lipid-containing (3-in-1) solutions — the finer 0.22 μm filter would block lipid particles

TPN administration and monitoring

Never stop TPN abruptly

If a TPN bag runs out and the next bag is not available, hang D10W (10% dextrose in water) at the same rate as the TPN infusion until the next bag arrives. Abrupt TPN cessation causes rebound hypoglycemia because the pancreas has upregulated insulin in response to the high-dextrose infusion. When discontinuing TPN intentionally, taper the rate over 1–2 hours rather than stopping it suddenly.

Blood glucose monitoring

Monitor blood glucose every 4–6 hours while on TPN. Target for critically ill patients: 140–180 mg/dL (per SCCM/ASPEN guidelines). Hyperglycemia above 180 mg/dL increases infection risk, impairs wound healing, and is associated with worse outcomes. An insulin infusion or correction doses may be added to the TPN bag by pharmacy or administered separately.

Daily electrolyte monitoring

TPN requires intensive lab monitoring, especially in the first week. Assess daily:

  • Sodium, potassium, chloride, bicarbonate — TPN bags are formulated with electrolytes; adjust based on daily labs
  • Phosphorus, magnesium, calcium — critical in refeeding syndrome risk (see below)
  • Blood urea nitrogen (BUN), creatinine — assess tolerance of amino acid load and renal function
  • Triglycerides — if lipid emulsion is included, check triglycerides baseline and weekly (or if nausea, abdominal pain, or pancreatitis symptoms develop); hold lipids if triglycerides exceed 400 mg/dL
  • Prealbumin/albumin — weekly nutritional markers; prealbumin (half-life 2–3 days) is more sensitive than albumin (half-life 20 days) for tracking acute nutritional status

Daily weights and strict I&O

  • Weigh patients daily, same time, same scale, same clothing or bedding configuration.
  • Rapid weight gain (>0.5 kg/day) suggests fluid retention, not lean mass accrual.
  • Strict I&O every shift — TPN volume counts as fluid intake. Watch for signs of fluid overload (peripheral edema, pulmonary crackles, increased respiratory work).

CLABSI prevention

Central line-associated bloodstream infection is the most serious complication of TPN. Prevention is a nursing responsibility:

  • Strict aseptic technique for all line access — mask and sterile gloves when accessing the TPN port
  • Change IV tubing every 24 hours for lipid-containing (3-in-1) solutions; every 72–96 hours for non-lipid solutions (per CDC guidelines)
  • Perform daily central line site assessments: inspect for redness, swelling, drainage, or tenderness
  • Apply and change dressing per central line bundle protocol — typically transparent semipermeable dressing every 7 days or when soiled/non-adherent, gauze dressing every 2 days
  • Monitor for CLABSI signs: fever, chills, rigors, site erythema, leukocytosis — if suspected, draw blood cultures through the line and a peripheral site, notify the provider, and anticipate antibiotic orders

For full central line care protocols, see central line nursing care and infection control and isolation precautions.


Refeeding syndrome

Refeeding syndrome is a potentially life-threatening metabolic complication that occurs when nutrition — enteral or parenteral — is restarted in a severely malnourished patient. The risk is highest in the first 72 hours of refeeding.

Mechanism

During prolonged starvation, the body shifts to fat and protein catabolism. Intracellular stores of phosphorus, potassium, and magnesium are depleted, but serum levels may appear normal because these electrolytes equilibrate with the intravascular space. When carbohydrates are reintroduced:

  1. The pancreas surges insulin in response to the glucose load.
  2. Insulin drives glucose, phosphorus, potassium, and magnesium from the bloodstream into cells.
  3. Serum levels of these electrolytes drop precipitously.
  4. Hypophosphatemia is the hallmark — and the most dangerous — electrolyte shift.

Consequences of hypophosphatemia

Phosphorus is essential for ATP synthesis and cellular energy metabolism. Severe hypophosphatemia causes:

  • Respiratory failure — diaphragm weakness, inability to wean from mechanical ventilation
  • Cardiac arrhythmias — potentially fatal
  • Neurological changes — confusion, seizures, coma
  • Hemolytic anemia — RBC destruction due to impaired energy metabolism

Patients at risk

  • Prolonged starvation (>5–7 days with little or no intake)
  • Anorexia nervosa or other severe eating disorders
  • Chronic alcoholism with malnutrition
  • Post-surgical NPO status >7 days
  • Cancer with severe cachexia
  • Prolonged malnutrition from any cause

Prevention protocol

  • Check and correct electrolytes before starting feeds — correct phosphorus, potassium, and magnesium deficiencies before initiating nutrition support
  • Start low, go slow — begin at 25% of goal caloric rate for the first 24–48 hours, then advance incrementally
  • Monitor daily electrolytes — phosphorus, potassium, magnesium, and calcium at minimum, for the first week
  • Thiamine (vitamin B1) supplementation — give before starting carbohydrates in high-risk patients; carbohydrate metabolism is thiamine-dependent and deficiency causes Wernicke’s encephalopathy

Refeeding syndrome electrolyte monitoring

Electrolyte Normal range Refeeding risk direction Monitoring frequency (first week)
Phosphorus 2.5–4.5 mg/dL Falls (hallmark electrolyte) Daily × 7 days
Potassium 3.5–5.0 mEq/L Falls (intracellular shift) Daily × 7 days
Magnesium 1.7–2.2 mg/dL Falls (intracellular shift) Daily × 7 days
Blood glucose 70–100 mg/dL (fasting) Rises (insulin response may overcorrect) q4–6h during initiation
Sodium 135–145 mEq/L May fluctuate with fluid shifts Daily × 7 days

TPN complications and nursing response

Complication Signs and symptoms Nursing action
CLABSI Fever, chills, rigors, line site erythema/drainage, leukocytosis Draw blood cultures (line + peripheral), hold TPN if ordered, notify provider, anticipate antibiotics; strict sterile technique going forward
Hyperglycemia BG >180 mg/dL, polyuria, thirst, altered mental status if severe Administer insulin per sliding scale or infusion; notify provider to adjust TPN dextrose concentration; monitor BG q4–6h
Hypertriglyceridemia Nausea, abdominal pain, lipemic serum, triglycerides >400 mg/dL; may precipitate pancreatitis Hold lipid emulsion, notify provider; check triglycerides; monitor for pancreatitis signs
Refeeding syndrome Hypophosphatemia, hypokalemia, hypomagnesemia; weakness, respiratory distress, arrhythmias Reduce feeding rate to 25% of goal, correct electrolytes aggressively, monitor daily labs, supplement thiamine
Hypoglycemia (abrupt TPN stop) BG <70 mg/dL, diaphoresis, tremor, confusion, tachycardia Hang D10W at same rate immediately; treat hypoglycemia per protocol; never abruptly discontinue TPN
Fluid overload Peripheral edema, crackles, increased weight, rising CVP Strict daily weights and I&O; notify provider; anticipate diuretic order or concentrated TPN formulation

NCLEX tips: enteral and parenteral nutrition

  1. Functional GI tract = enteral nutrition first. NCLEX will present a patient with a non-functional gut and expect you to select TPN. If the gut works at all, enteral is preferred.

  2. Auscultation (“whoosh” test) is NOT a valid method to confirm NG tube placement. X-ray is the gold standard. pH ≤5.5 supports gastric placement but is not definitive for small-bore tubes.

  3. HOB must be 30–45° during all tube feedings — and for 30–60 minutes after bolus feeds. This is the most reliable aspiration prevention measure.

  4. GRV >200–500 mL (institution-specific) = hold the feed. Notify the provider if GRV remains elevated after 1 hour. Reassess the feeding route.

  5. TPN requires a central line. Osmolarity >900 mOsm/L will sclerose peripheral veins. PICC, subclavian, or internal jugular lines are appropriate.

  6. TPN runs in a dedicated IV lumen — no piggybacking medications. This is a compatibility and infection control rule.

  7. Never abruptly stop TPN. Rebound hypoglycemia results from residual insulin secretion. Hang D10W if the bag runs out before the next one arrives. Taper over 1–2 hours when discontinuing.

  8. CLABSI prevention = TPN’s most important nursing responsibility. Strict aseptic technique always. Change tubing every 24h for lipid-containing solutions, q72–96h otherwise.

  9. Refeeding syndrome hallmark = hypophosphatemia. Phosphorus is the NCLEX answer for refeeding syndrome electrolyte questions. It causes respiratory failure, arrhythmias, and neurological changes.

  10. At-risk patients for refeeding syndrome: prolonged starvation, anorexia nervosa, chronic alcoholism, post-surgical NPO >7 days. Start low, go slow — 25% of goal rate for the first 24–48 hours.

  11. Monitor triglycerides in patients receiving lipid emulsion. Hold lipids if triglycerides >400 mg/dL — pancreatitis risk. See pancreatitis nursing care.

  12. Inline filter size matters: 0.22 μm for dextrose/amino acid solutions; 1.2 μm for lipid-containing (3-in-1) solutions.

  13. Blood glucose target in critical care TPN patients = 140–180 mg/dL. Higher targets increase infection risk; lower targets increase hypoglycemia risk.

  14. Prealbumin is a better short-term nutritional marker than albumin. Half-life: prealbumin = 2–3 days; albumin = 20 days. NCLEX may ask which reflects recent nutritional status — prealbumin.

  15. Jejunal routes (NJ, PEJ) = continuous feeds only. Bolus feeding into the jejunum overwhelms its absorption capacity. Gastric routes can accommodate bolus; jejunal routes cannot.


If you found this guide useful, these related topics build on the same foundational knowledge: